TY - JOUR
T1 - Management of inflamed conjunctival nevus with topical antiallergic medications
T2 - Case series
AU - Kato, Kumiko
AU - Takeuchi, Maki
AU - Yonekawa, Yuka
AU - Kashima, Yuzen
AU - Hirano, Koji
AU - Kondo, Mineo
N1 - Publisher Copyright:
© 2021 Kato et al.
PY - 2021
Y1 - 2021
N2 - Purpose: To report our findings in three cases of an inflamed conjunctival nevus whose size and degree of pigmentation were reduced by topical antiallergic and immunosuppressive ophthalmic solutions. Methods: Observational case series. Three patients with inflamed conjunctival nevus were examined by slit-lamp biomicroscopy, and the findings before and after the treatments were compared. Results: All three patients had a slightly pigmented and edematous conjunctival tumor at the corneal limbal area. The tumors were hyperemic, and papillae and follicles were present on the superior conjunctiva in all patients. All of the patients had an allergic predisposition. The antiallergic treatment not only resolved the hyperemia and edema of the palpebral conjunc-tiva, but also reduced the tumor size. In one case, the topical antiallergic agent alone led to a reduction of the tumor size. A combination of topical antiallergic agent and topical immunosuppressant was effective in reducing the tumor size and degree of pigmentation in the other two patients. Conclusion: The hyperemia and pigmentation in eyes with inflamed conjunctival nevus can be resolved by topical antiallergic agent and topical immunosuppressant without resection of the tumor.
AB - Purpose: To report our findings in three cases of an inflamed conjunctival nevus whose size and degree of pigmentation were reduced by topical antiallergic and immunosuppressive ophthalmic solutions. Methods: Observational case series. Three patients with inflamed conjunctival nevus were examined by slit-lamp biomicroscopy, and the findings before and after the treatments were compared. Results: All three patients had a slightly pigmented and edematous conjunctival tumor at the corneal limbal area. The tumors were hyperemic, and papillae and follicles were present on the superior conjunctiva in all patients. All of the patients had an allergic predisposition. The antiallergic treatment not only resolved the hyperemia and edema of the palpebral conjunc-tiva, but also reduced the tumor size. In one case, the topical antiallergic agent alone led to a reduction of the tumor size. A combination of topical antiallergic agent and topical immunosuppressant was effective in reducing the tumor size and degree of pigmentation in the other two patients. Conclusion: The hyperemia and pigmentation in eyes with inflamed conjunctival nevus can be resolved by topical antiallergic agent and topical immunosuppressant without resection of the tumor.
UR - http://www.scopus.com/inward/record.url?scp=85101376091&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101376091&partnerID=8YFLogxK
U2 - 10.2147/OPTH.S299288
DO - 10.2147/OPTH.S299288
M3 - Article
AN - SCOPUS:85101376091
SN - 1177-5467
VL - 15
SP - 559
EP - 564
JO - Clinical Ophthalmology
JF - Clinical Ophthalmology
ER -